MarketCap
Facebook
X
TelegramGeschäftsbericht 2024
hinzugefügt 21.02.2026
InflaRx N.V. Kurshistorie 2011-2026 | IFRX
Kurshistorie Jährlich InflaRx N.V.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.15 | 1.49 | 3.64 | 3.57 | 5.34 | 3.23 | 32.8 | 23.9 | - | - | - | - | - | - |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 32.8 | 1.15 | 9.39 |
Kurshistorie anderer Aktien in der Pharmaeinzelhändler
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Aptorum Group Limited
APM
|
0.75 | $ 0.82 | 1.9 % | $ 4.47 M |  China |
 |
Aquestive Therapeutics
AQST
|
2.79 | $ 4.18 | 2.32 % | $ 363 M |  USA |
 |
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M |  Germany |
 |
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
3.37 | - | 4.01 % | $ 150 M |  Canada |
 |
Adverum Biotechnologies
ADVM
|
3.86 | - | - | $ 86.2 M | USA |
 |
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | USA |
 |
argenx SE
ARGX
|
615 | $ 832.14 | -0.97 % | $ 25 B |  Niderland |
 |
I-Mab
IMAB
|
0.68 | - | - | $ 866 M | China |
 |
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | USA |
 |
Ascendis Pharma A/S
ASND
|
216 | $ 232.76 | -0.95 % | $ 5 B |  Danmark |
 |
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M |  France |
 |
Albireo Pharma
ALBO
|
28.5 | - | -0.23 % | $ 916 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
0.383 | - | 3.16 % | $ 1.9 M | USA |
 |
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | USA |
 |
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alterity Therapeutics Limited
ATHE
|
0.58 | $ 3.34 | 0.27 % | $ 8.04 B |  Australia |
 |
Akouos
AKUS
|
5.34 | - | 0.23 % | $ 488 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
0.57 | - | - | $ 10.1 M | USA |
 |
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | USA |
 |
Atea Pharmaceuticals
AVIR
|
3.02 | $ 4.59 | -1.4 % | $ 387 M | USA |
 |
Acer Therapeutics
ACER
|
0.77 | - | 2.71 % | $ 14 M | USA |
 |
Aravive
ARAV
|
1.66 | - | -13.39 % | $ 1.45 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.3 | - | - | $ 26.5 M | USA |
 |
Avenue Therapeutics
ATXI
|
0.42 | - | -52.27 % | $ 4.45 M | USA |
 |
Axsome Therapeutics
AXSM
|
174 | $ 165.2 | -2.79 % | $ 8.22 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.5 | - | - | $ 7.46 M |  Israel |
 |
Atreca
BCEL
|
1.27 | - | -11.76 % | $ 5.79 M | USA |
 |
Alpine Immune Sciences
ALPN
|
8.04 | - | - | $ 2.17 B | USA |
 |
BioDelivery Sciences International
BDSI
|
3.1 | - | -4.8 % | $ 255 M | USA |
 |
BioVie
BIVI
|
1.65 | $ 1.25 | 0.1 % | $ 1.85 M | USA |
 |
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M | Canada |
 |
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Biogen
BIIB
|
201 | $ 190.58 | -2.33 % | $ 27.9 B | USA |
 |
BioMarin Pharmaceutical
BMRN
|
69 | $ 61.56 | -1.7 % | $ 11.7 B | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
0.27 | - | -9.72 % | $ 5.89 M | USA |
 |
Baudax Bio
BXRX
|
2.35 | - | 0.59 % | $ 63 K | USA |
 |
Aptose Biosciences
APTO
|
3.32 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
0.14 | - | -39.0 % | $ 4.57 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
0.22 | - | 17.91 % | $ 11.1 M | USA |
 |
BioNTech SE
BNTX
|
95.4 | $ 111.01 | 0.11 % | $ 27.2 B | Germany |
 |
Amneal Pharmaceuticals
AMRX
|
5.91 | $ 14.68 | 0.1 % | $ 4.54 B | USA |
 |
Capricor Therapeutics
CAPR
|
5.8 | $ 28.39 | 1.72 % | $ 760 M | USA |
 |
CASI Pharmaceuticals
CASI
|
8.4 | $ 0.35 | -55.89 % | $ 47.6 M | USA |